Novartis influenza A H1N1 vaccine clinical data
…been approved for use in the US. A media release is no substitute for revealing clinical trial results in a peer-reviewed scientific journal. Novartis indicates that the vaccine trial will…
Search Results for: Trial by Error
A Long-Awaited Vaccine
…RSV F antigen and the adjuvant are supplied separately and combined prior to administration of the mixture as a single intramuscular injection. Phase III clinical trials engaging 25,000 adults over…
H5N1 expert says ‘The virus is definitely mutating’
…error-prone nucleic acid polymerases. The error rate for RNA virus genomes is phenomenal, because the viral polymerases cannot correct its mistakes. The error rates for viral RNA-dependent RNA polymerases have…
Virology 101
…The abundant and diverse viruses of the seas Chikungunya: An exotic virus on the move Lujo virus, a new hemorrhagic fever virus from Southern Africa The error-prone ways of RNA…
US to redirect $1 billion to study adjuvant for influenza vaccine
…influenza strain, and to conduct clinical trials this summer to determine if an adjuvant can be used. If this money is being taken away from research projects, then it’s a…
An open letter to PLoS One
…one in a series of papers highlighting results from the PACE study, the largest trial of treatments for the illness, also known as ME/CFS. Psychologist James Coyne has been seeking…